ALT - Altimmune, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1111
Avg. Estimate-0.52-0.52-1.81-1.92
Low Estimate-0.52-0.52-1.81-1.92
High Estimate-0.52-0.52-1.81-1.92
Year Ago EPS-0.26-0.73-1.6-1.81
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1111
Avg. Estimate500k500k3.7MN/A
Low Estimate500k500k3.7MN/A
High Estimate500k500k3.7MN/A
Year Ago Sales1.63M643k5.8M3.7M
Sales Growth (year/est)-69.20%-22.20%-36.20%N/A
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.25-0.19-0.26-0.32
EPS Actual-0.26-0.73-0.25-0.26
Difference-0.01-0.540.010.06
Surprise %-4.00%-284.20%3.80%18.80%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.52-0.52-1.81-1.92
7 Days Ago-0.52-0.52-1.81-1.92
30 Days Ago-0.52-0.52-1.81-1.92
60 Days Ago-0.32-0.33-1.41-1.3
90 Days Ago-0.32-0.33-1.41-1.3
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALTIndustrySectorS&P 500
Current Qtr.-100.00%N/AN/AN/A
Next Qtr.28.80%N/AN/AN/A
Current Year-13.10%N/AN/AN/A
Next Year-6.10%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A